Healio

Lebrikizumab improves atopic dermatitis of the head, neck

Please provide your email address to receive an email when new articles are posted on . WAILEA, Hawaii — Atopic dermatitis of the head and neck was improved in patients treated with lebrikizumab, ...
Medical Dialogues

Real-World Evidence Supports Dupilumab in Pediatric and Adult head and neck atopic dermatitis Patients: Study

Researchers have found in a new real-world study that dupilumab was an effective and safe therapeutic option for head and ...
Healio

Head and neck atopic dermatitis improves with upadacitinib treatment

Please provide your email address to receive an email when new articles are posted on . Patients with head and neck AD experienced greater improvement with upadacitinib than placebo. EASI, DLQI and ...
Seeking Alpha

New Analysis Demonstrates the Efficacy of RINVOQ® (upadacitinib) in Atopic Dermatitis with Varying Degrees of Severity in Head and Neck Involvement

Primary efficacy and safety results from these ongoing pivotal studies have been previously reported: https://rb.gy/oqscek. "Despite taking steps to manage their condition, many patients with atopic ...
Medscape

More Systemic Therapies Coming for Pediatric Skin Diseases

The number of systemic anti-inflammatory therapies for dermatologic diseases in children is expected to grow in 2026.

Assisted reproductive technology associated with higher risk of childhood atopic diseases

Collaborating institutions in Taiwan report higher risks of atopic disease among children conceived via assisted reproductive ...
WREG

New Analysis Demonstrates the Efficacy of RINVOQ® (upadacitinib) in Atopic Dermatitis with Varying Degrees of Severity in Head and Neck Involvement

NORTH CHICAGO, Ill., Sept. 25, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The ...